Speaking to reporters after a meeting with AstraZeneca Managing Director Gagan Singh Bedi, he said the first phase of trials of the vaccine were encouraging

Zydus Cadila's COVID-19 candidate vaccine ZyCov-D, which is currently undergoing second phase of clinical trials in India, is likely to enter Phase III final stage of clinical trials by December 2020

Amid ongoing coronavirus pandemic, Johnson & Johnson has said that the first batches of its COVID-19 vaccine could be available as soon as in January

The outcome of immunogenicity blood tests conducted on a subgroup of older study participants echoed data published in July this year that revealed that the coronavirus vaccine produced robust immune responses in healthy adults aged 18-55 years

Samsung's Lee Kun-hee leaves behind $21 billion wealth for inheritance; COVID-19 recovery rate in India touches 90%, only 8.5% of total caseload active; YES Bank aims to cut operational expenses by 20% in FY21. Watch this and more on News Blast. BT News Podcast: YES Bank aims to cut operational expenses by 20% in FY21

Coronavirus vaccine: The pharma company plans to start late-stage trials of the vaccine candidate next month. Over 26,000 candidates would be monitored for the vaccine candidate's efficacy

Airlines allowed to fly 12,983 weekly domestic flights in winter scheduleThe Directorate General of Civil Aviation has approved 12,983 weekly domestic flights for the winter schedule. This schedule began on Sunday and will end on March 27 next year. In last year's winter schedule, the aviation regulator had approved 23,307 weekly domestic flights. Currently, airlines in India are allowed to operate a maximum 60 per cent of pre-COVID weekly domestic flights.Coronavirus vaccine: AstraZeneca, ...

Seventy-five per cent of the new recoveries were observed to be concentrated in 10 states and Union territories -- Maharashtra, Karnataka, Kerala, Tamil Nadu, West Bengal, Delhi, Andhra Pradesh, Assam, Uttar Pradesh and Chhattisgarh

Coronavirus vaccine update: Testing of the AstraZeneca vaccine, developed with Oxford University, has already resumed in the United Kingdom, Brazil, South Africa and Japan

Covaxin, the coronavirus vaccine being developed by Bharat Biotech in collaboration with the Indian Council of Medical Research (ICMR), is expected to be at least 60 per cent effective

Serum Institute of India (SII) has teamed up with Merck KGaA, Germany, to develop COVID-19 fighting monoclonal antibodies (mAbs), made by cloning a unique white blood cell to increase immunity and fight diseases, along with drug research driven nonprofit scientific research organization IAVI and Scripps Research

Covaxin, the COVID-19 vaccine being developed by Bharat Biotech in collaboration with the Indian Council of Medical Research (ICMR), has received the approval of Drugs Controller General of India (DCGI's) Expert Committee to start the final phase of trials

Serum has floated a new company Serum Institute Life Sciences (SILS) that will exclusively focus on developing, producing and supplying pandemic vaccines

Kia Motors India on Wednesday said it has received over 50,000 bookings for its compact SUV Sonet within two months of commencing the process; The International Monetary Fund slashed this year's economic forecast for Asia, reflecting a sharper-than-expected contraction in countries like India; In wake of a deep global recession amid a still unchecked pandemic, the global economy is estimated to contract by 4.3 per cent this year, leaving global output short by over $6 trillion by the year end. Watch this and more on News Blast.Also Read: Dr Reddy's Labs share slips over 4% as firm shuts plants after cyberattack

According to estimates by the Maharashtra State Onion Growers' Association (MSOGA), 50 per cent of kharif and late kharif onion crops were damaged by heavy rain

COVID-19 vaccine: The US government is \"cautiously optimistic\" that one or two vaccines, likely from Pfizer Inc or Moderna Inc, will be available by the end of the year

Flipkart's Big Billion Days sees 55% rise in digital payments, over 150% increase in EMI optionsThe annual festive season sale by Flipkart, The Big Billion Days (TBBD), which concluded on October 21 saw 1.5 times growth in the number of transacting sellers, amongst whom more than 35 per cent saw over thrice the sales compared to last year, said the company in a statement. Even as it added nearly 35 per cent new sellers on its platform, nearly 60 per cent of them were from Tier II and Tier II...

AstraZeneca vaccine trials: An AstraZeneca spokesperson, while declining to comment on the volunteer's death, said that there were no concerns that would lead the trials to be paused

Notably, Serum Institute of India is working with AstraZeneca and Oxford University to conduct trials and produce their vaccine candidate once it receives the required regulatory approvals

The Calcutta High Court has eased its order and allowed entry of up to 45 people at a time in a pandal. However, the court upheld its ban on assembly of people inside pandals for rituals like Pushpanjali and Sindoor Khela